Statement from Beth Battaglino, CEO RN-C, HealthyWomen, regarding access to oral contraception:
FDA approval of the first over-the-counter progestin-only oral contraceptive, Opill, is a major step toward dramatically increasing access to birth control across the country. Reflecting the sturdy body of scientific proofHealthyWomen supports over-the-counter access to hormonal contraceptives for women and those designated female at birth and the right of all individuals to access comprehensive sexual and reproductive health services to make choices that meet their own needs. .
Although some legislative approaches have increased access in some states, requirements such as pharmacy disbursement remain. barriers for many. Given the scientific evidence showing that access to over-the-counter contraception can be safely achieved, FDA approval will help ease barriers, allowing more people to control their own reproductive future, including avoiding unplanned pregnancies.
However, Opill must be affordable, a major factor in ensuring that women, especially those without health insurance, can access this new option.
HealthyWomen will continue to play a leadership role through policy advocacy and education of consumers and healthcare professionals, and support research related to innovative strategies to expand access, safety and affordability of hormonal contraceptives.
From articles on your site
Related articles on the web